22. University Hospital, Toulouse. MEsenchymal StEm Cells for Multiple
Sclerosis (MESEMS). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National
Library of Medicine (US). 2000- [cited 2016 July]. Available from:
https://clinicaltrials.gov/ct2/show/NCT02403947
NLM
Identifier:
NCT02403947.
23. The Cleveland Clinic. Autologous mesenchymal stem cell (msc)
transplantation in MS. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National
Library of Medicine (US). 2000- [cited 2016 July]. Available from:
https://clinicaltrials.gov/ct2/show/NCT00813969
NLM
Identifier:
NCT00813969.
24. Riordan NH, Ichim TE, Min WP, et al. Non-expanded adipose stromal
vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009 Apr 24;
7: 29. doi: 10.1186/1479-5876-7-29.
25. Translational Biosciences. Feasibility study of human umbilical cord
tissue-derived mesenchymal stem cells in patients with multiple sclerosis. In:
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US).
2000-
[cited
2016
July].
Available
from:
https://clinicaltrials.gov/ct2/show/NCT02034188 NLM Identifier: NCT02034188
Chương 8
1. Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z.
Transdifferentiation of human peripheral blood CD34+-enriched cell population
into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo.
Circulation. 2003; 108(17): 2070-3.
2. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion
and transdifferentiation account for the transformation of human peripheral blood
CD34-positive cells into cardiomyocytes in vivo. Circulation. 2004; 110(25):
3803-7.
3. Ma N, Stamm C, Kaminski A, et al. Human cord blood cells induce
angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res.
2005; 66(1): 45-54.
